Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
Molecules.
2022 May 24;27(11). doi: 10.3390/molecules27113371. PubMed PMID:
35684309; PubMed Central PMCID:
PMC9182553.
Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
Int J Mol Sci.
2022 Feb 19;23(4). doi: 10.3390/ijms23042301. PubMed PMID:
35216417; PubMed Central PMCID:
PMC8878013.
Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines.
Macromol Biosci.
2020 Oct;20(10):e2000170. doi: 10.1002/mabi.202000170. Epub 2020 Jul 30. PubMed PMID:
32734662; PubMed Central PMCID:
PMC7737380.
Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents.
RSC Adv.
2020 Aug 10;10(50):30223-30237. doi: 10.1039/d0ra06148d. eCollection 2020 Aug 10. PubMed PMID:
35518245; PubMed Central PMCID:
PMC9056317.
Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Molecules.
2019 Sep 6;24(18). doi: 10.3390/molecules24183242. PubMed PMID:
31489879; PubMed Central PMCID:
PMC6767252.
Tumor targeting peptides: novel therapeutic strategies in glioblastoma.
Curr Opin Pharmacol.
2019 Aug;47:14-19. doi: 10.1016/j.coph.2019.01.006. Epub 2019 Feb 15. Review. PubMed PMID:
30776641; PubMed Central PMCID:
PMC7288394.
Design, Synthesis, and Preliminary Studies of Spiro-isoxazoline-peroxides against Human Cytomegalovirus and Glioblastoma ∥.
J Org Chem.
2019 Jun 7;84(11):6992-7006. doi: 10.1021/acs.joc.9b00746. Epub 2019 May 17. PubMed PMID:
31066280.
Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.
J Drug Target.
2017 Jul;25(6):523-531. doi: 10.1080/1061186X.2017.1289537. Epub 2017 Feb 23. PubMed PMID:
28140690.
Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.
Molecules.
2015 Dec 4;20(12):21750-69. doi: 10.3390/molecules201219804. Review. PubMed PMID:
26690101; PubMed Central PMCID:
PMC6331894.
Cell-penetrating peptides: strategies for anticancer treatment.
Trends Mol Med.
2015 Sep;21(9):560-70. doi: 10.1016/j.molmed.2015.06.005. Epub 2015 Jul 15. Review. PubMed PMID:
26186888.
Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
Expert Opin Drug Deliv.
2015 Apr;12(4):653-67. doi: 10.1517/17425247.2015.974546. Epub 2014 Oct 28. Review. PubMed PMID:
25350837.
Synthesis and Investigation of Novel Spiro-isoxazolines as Anti-Cancer Agents.
Tetrahedron Lett.
2015 Apr 1;56(14):1794-1797. doi: 10.1016/j.tetlet.2015.02.059. PubMed PMID:
25821250; PubMed Central PMCID:
PMC4371604.
Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer.
Drug Des Devel Ther.
2014;8:1649-58. doi: 10.2147/DDDT.S60451. eCollection 2014. PubMed PMID:
25336913; PubMed Central PMCID:
PMC4199967.
The design and delivery of a PKA inhibitory polypeptide to treat SCA1.
J Neurochem.
2014 Oct;131(1):101-14. doi: 10.1111/jnc.12782. Epub 2014 Jun 23. PubMed PMID:
24903464.
Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.
Cerebellum.
2014 Oct;13(5):596-606. doi: 10.1007/s12311-014-0576-1. PubMed PMID:
24930030.
Elastin-like polypeptides: the influence of its molecular weight on local hyperthermia-induced tumor accumulation.
Eur J Pharm Biopharm.
2014 Oct;88(2):382-9. doi: 10.1016/j.ejpb.2014.05.016. Epub 2014 May 24. PubMed PMID:
24866938; NIHMSID:NIHMS599216.
Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine.
Cancer Lett.
2014 Jun 28;348(1-2):177-84. doi: 10.1016/j.canlet.2014.03.021. Epub 2014 Mar 26. PubMed PMID:
24680816.
Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
Ther Deliv.
2014 Apr;5(4):429-45. doi: 10.4155/tde.14.14. Review. PubMed PMID:
24856169.
Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150].
Biochemistry.
2014 Feb 18;53(6):1081-91. doi: 10.1021/bi400955w. Epub 2014 Feb 4. PubMed PMID:
24450599; PubMed Central PMCID:
PMC3985474.
Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines.
Anticancer Drugs.
2014 Feb;25(2):189-99. doi: 10.1097/CAD.0000000000000036. PubMed PMID:
24113592; PubMed Central PMCID:
PMC3915535.
Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150].
Biophys J.
2013 May 7;104(9):2009-21. doi: 10.1016/j.bpj.2013.03.040. PubMed PMID:
23663844; PubMed Central PMCID:
PMC3647178.
Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model.
PLoS One.
2013;8(1):e55104. doi: 10.1371/journal.pone.0055104. Epub 2013 Jan 25. PubMed PMID:
23372821; PubMed Central PMCID:
PMC3555869.
Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
Int J Pharm.
2012 Oct 15;436(1-2):825-32. doi: 10.1016/j.ijpharm.2012.07.043. Epub 2012 Jul 28. PubMed PMID:
22850291; PubMed Central PMCID:
PMC3465682.
Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.
Int J Pept Res Ther.
2012 Sep;18(3):227-237. doi: 10.1007/s10989-012-9295-y. PubMed PMID:
23105921; PubMed Central PMCID:
PMC3480076.
Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.
Mol Cancer Ther.
2012 Jul;11(7):1547-56. doi: 10.1158/1535-7163.MCT-11-0998. Epub 2012 Apr 24. PubMed PMID:
22532601; PubMed Central PMCID:
PMC3392364.
A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.
Cancer Lett.
2012 Jun 28;319(2):136-143. doi: 10.1016/j.canlet.2011.12.042. Epub 2012 Jan 17. PubMed PMID:
22261328; PubMed Central PMCID:
PMC3536021.
A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis.
Invest New Drugs.
2012 Feb;30(1):236-48. doi: 10.1007/s10637-010-9560-x. Epub 2010 Oct 12. PubMed PMID:
20938714.
The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
Neuroscience.
2011 Dec 1;197:369-80. doi: 10.1016/j.neuroscience.2011.09.025. Epub 2011 Sep 17. PubMed PMID:
21958864; PubMed Central PMCID:
PMC3210406.
Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.
Adv Drug Deliv Rev.
2010 Dec 30;62(15):1486-96. doi: 10.1016/j.addr.2010.05.003. Epub 2010 May 15. Review. PubMed PMID:
20478348; PubMed Central PMCID:
PMC2964383.
A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation.
Peptides.
2010 May;31(5):834-41. doi: 10.1016/j.peptides.2010.02.007. Epub 2010 Feb 16. PubMed PMID:
20167239; PubMed Central PMCID:
PMC2872552.
Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
Int J Cancer.
2010 Jan 15;126(2):533-44. doi: 10.1002/ijc.24725. PubMed PMID:
19588502; PubMed Central PMCID:
PMC2795124.
Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
Expert Opin Drug Deliv.
2009 Oct;6(10):1049-64. doi: 10.1517/17425240903158909. Review. PubMed PMID:
19743895.
Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.
Expert Opin Drug Deliv.
2009 Oct;6(10):1033-47. doi: 10.1517/17425240903143745. Review. PubMed PMID:
19637980.
Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer.
Molecules.
2009 Jun 4;14(6):1999-2015. doi: 10.3390/molecules14061999. PubMed PMID:
19513001; PubMed Central PMCID:
PMC6254221.
Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
J Control Release.
2009 Apr 2;135(1):2-10. doi: 10.1016/j.jconrel.2008.11.015. Epub 2008 Nov 28. PubMed PMID:
19095020.
Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP.
Clin Exp Metastasis.
2009;26(3):251-60. doi: 10.1007/s10585-009-9237-z. Epub 2009 Jan 25. PubMed PMID:
19169893.
Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
Expert Opin Drug Deliv.
2008 Mar;5(3):353-69. doi: 10.1517/17425247.5.3.353. Review. PubMed PMID:
18318656.
Chapter 17: Application of laser tweezers to studies of membrane-cytoskeleton adhesion.
Methods Cell Biol.
2008;89:451-66. doi: 10.1016/S0091-679X(08)00617-1. PubMed PMID:
19118686.
A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells.
J Drug Target.
2007 Nov;15(9):611-22. doi: 10.1080/10611860701502780. PubMed PMID:
17968715.
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
Invest New Drugs.
2007 Aug;25(4):313-26. doi: 10.1007/s10637-007-9053-8. Epub 2007 May 5. PubMed PMID:
17483874.
Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Biochem Pharmacol.
2007 Mar 1;73(5):620-31. doi: 10.1016/j.bcp.2006.10.028. Epub 2006 Nov 10. PubMed PMID:
17161827.
Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc.
Biochem Pharmacol.
2006 Jan 12;71(3):248-56. doi: 10.1016/j.bcp.2005.10.041. PubMed PMID:
16316634.
Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
J Control Release.
2005 Nov 28;108(2-3):396-408. doi: 10.1016/j.jconrel.2005.08.007. Epub 2005 Sep 12. PubMed PMID:
16157413.
Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.
Mol Cancer Ther.
2005 Jul;4(7):1076-85. doi: 10.1158/1535-7163.MCT-04-0253. PubMed PMID:
16020665.
Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy.
J Control Release.
2003 Aug 28;91(1-2):31-43. doi: 10.1016/s0168-3659(03)00216-5. PubMed PMID:
12932635.
Targeted drug delivery by thermally responsive polymers.
Adv Drug Deliv Rev.
2002 Sep 13;54(5):613-30. doi: 10.1016/s0169-409x(02)00041-8. Review. PubMed PMID:
12204595.
Phospholipase C activation by anesthetics decreases membrane-cytoskeleton adhesion.
J Cell Sci.
2001 Oct;114(Pt 20):3759-66. doi: 10.1242/jcs.114.20.3759. PubMed PMID:
11707527.
Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.
Cancer Res.
2001 Oct 1;61(19):7163-70. PubMed PMID:
11585750.
Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion.
Cell.
2000 Jan 21;100(2):221-8. doi: 10.1016/s0092-8674(00)81560-3. PubMed PMID:
10660045.
Cell spreading and lamellipodial extension rate is regulated by membrane tension.
J Cell Biol.
2000 Jan 10;148(1):127-36. doi: 10.1083/jcb.148.1.127. PubMed PMID:
10629223; PubMed Central PMCID:
PMC2156205.
What would you like to do?